메뉴 건너뛰기




Volumn 59, Issue 116, 2012, Pages 1043-1047

Terlipressin in the treatment of late phase catecholamine-resistant septic shock

Author keywords

Norepinephrine; Refractory septic shock; Terlipressin

Indexed keywords

HYPERTENSIVE AGENT; NORADRENALIN; TERLIPRESSIN;

EID: 84861408233     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10550     Document Type: Article
Times cited : (33)

References (24)
  • 1
    • 0036213966 scopus 로고    scopus 로고
    • Epidemiology of sepsis and infection in ICU patients from an international cohort study
    • Alberti C, Brun-Buisson C, Burchardi H et al.: Epidemiology of sepsis and infection in ICU patients from an international cohort study. Intensive Care Med 2002; 28:108-121.
    • (2002) Intensive Care Med , vol.28 , pp. 108-121
    • Alberti, C.1    Brun-Buisson, C.2    Burchardi, H.3
  • 3
    • 37549020378 scopus 로고    scopus 로고
    • Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock
    • Dellinger RP, Levy MM, Carlet JM, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; 36(1):296-327.
    • (2008) Crit Care Med , vol.36 , Issue.1 , pp. 296-327
    • Dellinger, R.P.1    Levy, M.M.2    Carlet, J.M.3
  • 4
    • 77649282276 scopus 로고    scopus 로고
    • Comparison of dopamine and norepinephrine in the treatment of shock
    • De Backer D, Biston P, Devriendt J, et al.: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362(9):779-789.
    • (2010) N Engl J Med , vol.362 , Issue.9 , pp. 779-789
    • De Backer, D.1    Biston, P.2    Devriendt, J.3
  • 5
    • 0031026648 scopus 로고    scopus 로고
    • Vasopressin deficiency contributes to the vasodilation of septic shock
    • Landry DW, Levin HR, Gallant EM, et al.: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95(5):1122-1225.
    • (1997) Circulation , vol.95 , Issue.5 , pp. 1122-1225
    • Landry, D.W.1    Levin, H.R.2    Gallant, E.M.3
  • 6
    • 0035940129 scopus 로고    scopus 로고
    • The pathogenesis of vasodilatory shock
    • Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345(8):588-595.
    • (2001) N Engl J Med , vol.345 , Issue.8 , pp. 588-595
    • Landry, D.W.1    Oliver, J.A.2
  • 7
    • 0038468344 scopus 로고    scopus 로고
    • Circulating vasopressin levels in septic shock
    • Sharshar T, Blanchard A, Paillard M, et al.: Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31(6):1752-1758.
    • (2003) Crit Care Med , vol.31 , Issue.6 , pp. 1752-1758
    • Sharshar, T.1    Blanchard, A.2    Paillard, M.3
  • 8
    • 0038001553 scopus 로고    scopus 로고
    • Vasopressin deficiency in the syndrome of irreversible shock
    • Robin JK, Oliver JA, Landry DW: Vasopressin deficiency in the syndrome of irreversible shock. J Trauma 2003; 54(5):S149-154.
    • (2003) J Trauma , vol.54 , Issue.5
    • Robin, J.K.1    Oliver, J.A.2    Landry, D.W.3
  • 9
    • 0036187359 scopus 로고    scopus 로고
    • Beneficial effects of short-term vasopressin infusion during severe septic shock
    • Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96(3):576-582.
    • (2002) Anesthesiology , vol.96 , Issue.3 , pp. 576-582
    • Patel, B.M.1    Chittock, D.R.2    Russell, J.A.3    Walley, K.R.4
  • 10
    • 24944589992 scopus 로고    scopus 로고
    • Terlipressin or nor-epinephrine in hyperdynamic septic shock: A prospective, randomized study
    • Albanèse J, Leone M, Delmas A, Martin C: Terlipressin or nor-epinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 2005; 33(9):1897-1902.
    • (2005) Crit Care Med , vol.33 , Issue.9 , pp. 1897-1902
    • Albanèse, J.1    Leone, M.2    Delmas, A.3    Martin, C.4
  • 11
    • 40049109098 scopus 로고    scopus 로고
    • Vasopressin versus nor-epinephrine infusion in patients with septic shock
    • Russell JA, Walley KR, Singer J, et al.: Vasopressin versus nor-epinephrine infusion in patients with septic shock. N Engl J Med 2008; 358(9):877-887.
    • (2008) N Engl J Med , vol.358 , Issue.9 , pp. 877-887
    • Russell, J.A.1    Walley, K.R.2    Singer, J.3
  • 12
    • 69649083054 scopus 로고    scopus 로고
    • Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): A randomized, controlled pilot study
    • Morelli A, Ertmer C, Rehberg S, et al.: Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 2009; 13(4):R130.
    • (2009) Crit Care , vol.13 , Issue.4
    • Morelli, A.1    Ertmer, C.2    Rehberg, S.3
  • 13
    • 0030015661 scopus 로고    scopus 로고
    • The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
    • Vincent JL, Moreno R, Takala J, et al.: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22(7):707-710.
    • (1996) Intensive Care Med , vol.22 , Issue.7 , pp. 707-710
    • Vincent, J.L.1    Moreno, R.2    Takala, J.3
  • 14
    • 0028784689 scopus 로고
    • Multiple Organ Dysfunction Score: A reliable descriptor of a complex clinical outcome
    • Marschall JC, Cook DJ, Christou nV, et al.: Multiple Organ Dysfunction Score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-1652.
    • (1995) Crit Care Med , vol.23 , pp. 1638-1652
    • Marschall, J.C.1    Cook, D.J.2    Christou, N.V.3
  • 15
    • 0033847366 scopus 로고    scopus 로고
    • Effect of norepinephrine on the outcome of septic shock
    • Martin C, Viviand X, Leone M, Thirion X: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28(8):2758-2765.
    • (2000) Crit Care Med , vol.28 , Issue.8 , pp. 2758-2765
    • Martin, C.1    Viviand, X.2    Leone, M.3    Thirion, X.4
  • 16
    • 58849147094 scopus 로고    scopus 로고
    • Incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicentre study
    • Blanco J, Muriel-Bombín A, Sagredo V, et al.: Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008; 12(6):R158.
    • (2008) Crit Care , vol.12 , Issue.6
    • Blanco, J.1    Muriel-Bombín, A.2    Sagredo, V.3
  • 17
    • 33644584325 scopus 로고    scopus 로고
    • Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study
    • Sakr Y, Reinhart K, Vincent JL, et al.: Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006; 34(3):589-597.
    • (2006) Crit Care Med , vol.34 , Issue.3 , pp. 589-597
    • Sakr, Y.1    Reinhart, K.2    Vincent, J.L.3
  • 19
    • 0035159740 scopus 로고    scopus 로고
    • Assesment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study
    • Abraham E, Reinhart K, Svoboda P, et al.: Assesment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Critical Care Med 2001; 29:2081-2089.
    • (2001) Critical Care Med , vol.29 , pp. 2081-2089
    • Abraham, E.1    Reinhart, K.2    Svoboda, P.3
  • 20
    • 0038690407 scopus 로고    scopus 로고
    • Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis. A randomized controlled trial
    • Abraham E, Reinhart K, Opal S, et al.: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis. A randomized controlled trial. JAMA 2003; 290:238-247.
    • (2003) JAMA , vol.290 , pp. 238-247
    • Abraham, E.1    Reinhart, K.2    Opal, S.3
  • 21
    • 11144358131 scopus 로고    scopus 로고
    • Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock
    • Morelli A, Rocco M, Conti G, et al.: Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 2004; 30(4):597-604.
    • (2004) Intensive Care Med , vol.30 , Issue.4 , pp. 597-604
    • Morelli, A.1    Rocco, M.2    Conti, G.3
  • 22
    • 0034955593 scopus 로고    scopus 로고
    • Terlipressin for treating intraoperative hypotension: Can it unmask myocardial ischemia?
    • Medel J, Boccara G, Van de Steen E, et al.: Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg 2001; 93(1):53-55.
    • (2001) Anesth Analg , vol.93 , Issue.1 , pp. 53-55
    • Medel, J.1    Boccara, G.2    Van De Steen, E.3
  • 23
    • 42449145538 scopus 로고    scopus 로고
    • Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis
    • Lange M, Ertmer C, Westphal M.: Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 2008; 34(5):821-832.
    • (2008) Intensive Care Med , vol.34 , Issue.5 , pp. 821-832
    • Lange, M.1    Ertmer, C.2    Westphal, M.3
  • 24
    • 41949111747 scopus 로고    scopus 로고
    • Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: The DOBUPRESS study
    • Morelli A, Ertmer C, Lange M, et al.: Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth 2008; 100(4):494-503.
    • (2008) Br J Anaesth , vol.100 , Issue.4 , pp. 494-503
    • Morelli, A.1    Ertmer, C.2    Lange, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.